Engineering a Synthetic Dopamine-Responsive Riboswitch for In Vitro Biosensing

ACS Synth Biol. 2022 Jul 15;11(7):2275-2283. doi: 10.1021/acssynbio.1c00560. Epub 2022 Jul 1.

Abstract

The detection of chemicals using natural allosteric transcription factors is a powerful strategy for point-of-use molecular sensing, particularly using fieldable cell-free gene expression (CFE) systems. However, the reliance of detection schemes on characterized protein-based sensors limits the number of measurable analytes. One alternative solution to this issue is to develop new sensors by generating RNA aptamers against the target analyte and then incorporating them directly into a riboswitch scaffold for ligand-inducible genetic control of a reporter protein. However, this strategy has not generated more than a handful of successful portable cell-free molecular sensors. To address this gap, here we convert dopamine-binding aptamers into functional dopamine-sensing riboswitches that regulate gene expression in a freeze-dried CFE reaction. We then develop an assay for direct detection and semi-quantification of dopamine in human urine. We anticipate that this work will be broadly applicable for converting many in vitro-generated RNA aptamers into fieldable molecular diagnostics.

Keywords: TX-TL; aptamer; biosensing; cell-free gene expression; dopamine; human performance; riboswitch.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aptamers, Nucleotide* / metabolism
  • Dopamine / genetics
  • Gene Expression Regulation
  • Humans
  • Ligands
  • Riboswitch* / genetics

Substances

  • Aptamers, Nucleotide
  • Ligands
  • Riboswitch
  • Dopamine